7,600 Blood Pressure Bottles Recalled Nationwide

Understanding the Risks of High Blood Pressure

High blood pressure, or hypertension, is a significant health concern that affects millions of people worldwide. Health experts have noted that it was either a primary or contributing cause for over 664,000 deaths in 2023. The Cleveland Clinic highlights that hypertension is often referred to as a "silent killer" because many individuals may not experience noticeable symptoms. This lack of awareness can lead to severe complications if left untreated.

According to the American Heart Association, untreated high blood pressure can lead to various serious health issues, including sexual dysfunction, kidney disease, heart failure, and stroke. These conditions underscore the importance of regular monitoring and appropriate treatment for those diagnosed with hypertension.

A Recent Recall of a Trusted Blood Pressure Medication

In a recent development, a trusted drug combination used to treat high blood pressure has been recalled nationwide. The U.S. Food and Drug Administration (FDA) announced an ongoing recall of 7,668 bottles of Amlodipine and Benazepril HCL Capsules. This medication, sometimes known by the brand name Lotrel, was distributed throughout the United States.

The FDA cited an apparent labeling issue as the reason for the recall. Specifically, the affected products were labeled with the wrong expiration date—February 2027 instead of January 2027. This error could potentially lead to the use of expired medication, which poses risks to patients.

The recalling firm, Lupin Pharmaceuticals Inc., located in Naples, Florida, was also involved in a separate blood pressure medication recall reported on earlier this week. This recurrence raises concerns about the quality control processes within the pharmaceutical industry.

How the Medication Works

The medication in question is a combination of two drugs designed to lower blood pressure: amlodipine and benazepril. According to the Mayo Clinic, amlodipine functions as a calcium channel blocker, affecting the movement of calcium into the cells of the heart and blood vessels. Benazepril, on the other hand, is an angiotensin-converting enzyme (ACE) inhibitor that blocks a substance in the body responsible for tightening blood vessels.

Together, these drugs help relax blood vessels, thereby reducing blood pressure. However, the effectiveness of these medications relies on their proper formulation and accurate labeling.

The Importance of Expiration Dates

Taking expired medication can be dangerous, as highlighted by FDA guidelines. Once the expiration date has passed, there is no guarantee that the medicine will remain safe or effective. The FDA advises against using any medication that has exceeded its expiration date, emphasizing the potential for chemical changes or reduced potency.

Details About the Affected Product

The specific product involved in the recall includes:

• Amlodipine and Benazepril HCL Capsules USP 2.5 mg/10 mg
• 100 Capsules bottle
• Rx Only (Prescription Only)
• Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL, 34108, United States
• Manufactured by: Lupin Limited, Goa 103 722, India
• NDC (National Drug Code): 68180-755-01
• Lot Code: GB01616
• Expiration: 2/28/2027

FDA's Classification of the Recall

The FDA classified this recall as a Class II event, indicating that the use of or exposure to the violative product may cause temporary or medically reversible adverse health consequences. However, the probability of serious adverse health consequences is considered remote. This classification reflects the agency’s assessment of the potential risks associated with the recalled medication.

Staying Informed on Health Matters

For daily wellness updates and more information on health-related topics, readers can subscribe to the Healthy by Reader’s Digest newsletter and follow The Healthy on social media platforms such as Facebook and Instagram. Staying informed about recalls and health advisories is essential for maintaining personal well-being and making informed decisions about medication use.